Abstract: An engine exhaust system comprising an exhaust pipe routing an exhaust flow through a bend, and being in fluid communication with a catalyst downstream of the bend. An injector mounted to the exterior of the exhaust pipe, the injector with a tip disposed within the exhaust pipe at the bend, for injecting liquid reductant into the exhaust pipe. A shield member mounted in the exhaust pipe, the shield member comprising a generally tubular or frustoconical structure having a proximal and a distal end, the proximal end being disposed such that the injection tip is inside the shield member, the distal end being disposed towards a centerline of the exhaust pipe. A vane mounted in relation to the shield member, the vane being arranged to direct a proportion of exhaust flow from upstream of the bend in a substantially arcuate path into the proximal end of the shield member.

Abstract: An engine exhaust system comprising an exhaust pipe routing an exhaust flow through a bend, and being in fluid communication with a catalyst downstream of the bend. An injector mounted to the exterior of the exhaust pipe, the injector with a tip disposed within the exhaust pipe at the bend, for injecting liquid reductant into the exhaust pipe. A shield member mounted in the exhaust pipe, the shield member comprising a generally tubular or frustoconical structure having proximal and distal end, the proximal end being disposed such that the injection tip is inside the shield member, the distal end being disposed towards a centerline of the exhaust pipe. A vane mounted in relation to the shield member, the vane being arranged to direct a proportion of exhaust flow from upstream of the bend in a substantially arcuate path into the proximal end of the shield member.

Abstract: The present invention relates generally to the fields of neuroscience, bioinformatics and molecular biology. More particularly, the invention relates to newly identified polynucleotides that encode G-protein coupled receptors (GPCRs), the use of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides. The invention relates also to identifying compounds which may be agonists, antagonists and/or inhibitors of GPCRs, and therefore potentially useful in therapy.